Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Piramal announces launch of Cinacalcet by its partner, Slate Run Pharmaceuticals, in the U.S.

Posted On: 2019-03-12 14:27:29

Piramal Enterprises Limited ('PEL', 'Piramal', NSE: PEL, BSE: 500302) announced that one of its partners for its global pharma businesses - Slate Run Pharmaceuticals LLC. ('Slate Run'), has launched generic cinacalcet hydrochloride tablets (30mg, 60mg and 90mg) in the United States.

Piramal's subsidiary, Piramal Healthcare (UK) Limited ('PHL'), has partnered with Slate Run Pharmaceuticals with the goal of developing a non-infringing formulation of cinacalcet hydrochloride tablets. Cinacalcet tablets are indicated for the treatment of secondary hyperthyroidism ('HPT') in adult chronic kidney disease patients on dialysis and hypercalcemia in adult patients with parathyroid carcinoma.

"As part of our patient focus strategy, we are working with global pharmaceutical firms, to co-develop products, where our R&D competencies can bring about a differentiated and cost effective value proposition for the global healthcare system. With world class R&D and fully integrated network of manufacturing capabilities across the globe, for both drug substance and drug product, Piramal is uniquely positioned to solve both complex chemistries and formulation challenges in the pharmaceutical domain with innovative solutions for partners." said Vivek Sharma, CEO - Piramal Pharma Solutions, Piramal Group.

PHL received the final Abbreviated New Drug Application ('ANDA') approval for its generic abbreviated bio-equivalent ('AB') rated version of Amgen Inc.'s Sensipar® (cinacalcet hydrochloride) tablets on August 1, 2018. Piramal received a favourable US district court ruling which holds that Piramal's generic version does not infringe any of the asserted claims of Amgen's Patent No. 9,375,405. Amgen has filed an appeal which is currently pending in the U.S. Court of Appeals for the Federal Circuit.

Piramal will continue to focus on assisting its partners with a culture that is built around the pillars of Customer Centricity, Quality, and Innovation.

Shares of PIRAMAL ENTERPRISES LTD. was last trading in BSE at Rs.2661.15 as compared to the previous close of Rs. 2585.95. The total number of shares traded during the day was 43262 in over 2078 trades.

The stock hit an intraday high of Rs. 2675.05 and intraday low of 2586. The net turnover during the day was Rs. 114817611.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Punjab & Sind Bank declares Financial Results for the Quarter/ Year Ended 31.03.2019

Excel Industries Ltd Board approves Dividend of Rs. 18.75

NGL Fine-Chem Ltd board recommends final dividend of Rs. 1.75

NCC Ltd Board recommends Dividend of Rs. 1.50 for FY19

Dixon Technologies India Ltd Board recommends Final Dividend of Rs. 2

Housing and Urban Development Corporation Ltd Board approves Dividend for 2018-19

PNC Infratech Ltd Board approves Dividend of Rs. 0.50

Zuari Global Ltd Board recommends Dividend of Rs. 1 for 2018-19

BATA India Ltd Board recommends Dividend of Rs. 6.25 for FY19

Whirlpool of India Ltd Board recommends Dividend for FY 2018-19

Grasim Industries Ltd Board recommends Dividend of Rs. 7

Meghmani Organics Ltd Board recommends Final Dividend of Rs. 0.40 for FY19

Ashok Leyland Ltd Board recommends Dividend of Rs. 3.10

Pudumjee Paper Products Ltd Board approves Dividend of Rs. 0.15 for 2018-19

H G Infra Engineering Ltd Board approves Dividend of Rs. 0.50

Page Industries Ltd Board approves Dividend of Rs. 41

Ponni Sugars Erode Ltd board recommends Dividend of Rs. 2 for 2018-19

Kaira Can Co Ltd Board recommends Dividend of Rs. 6.50

Sudarshan Chemical Industries Ltd Board recommends Dividend of Rs. 6

Varroc Engineering Ltd announces Q4 & FY19 results

Zenith Fibres Ltd Board recommends Dividend for 2018-19

Varroc Engineering Ltd board recommends dividend of Rs. 4 for 2018-19

Ashoka Buildcon Limited Consolidated Revenue crossed Rs 5,000 Crores in FY19

Lancer Container Lines Ltd declares Q4, FY19 results

CG-VAK Software & Exports Ltd Board approves Dividend for FY 2018-19

DIL LTD Board recommends Final Dividend of Rs. 1.25

Welspun India Ltd Bord recommends Dividend of Rs. 0.30

HeidelbergCement India Ltd Board approves Dividend of Rs. 3

Vardhman Holdings Ltd board recommends dividend of Rs. 5 for FY19

Emmbi Industries Ltd Board recommends Dividend for 2018-19

Unichem Laboratories Ltd Board recommends Dividend of Rs. 4 for FY2018-19

Panama Petrochem Ltd Board recommends Dividend of Rs. 1.20 for FY19

Kaycee Industries Ltd Board recommends Dividend of Rs. 10 for 2018-19

Salzer Electronics Ltd board recommends dividend of Rs. 1.60 for 2018-19

AMJ Land Holdings Ltd Board approves Dividend of Rs. 0.30 for 2018-19

Empire Industries Ltd board recommends dividend of Rs. 25 for 2018-19

Advanced Enzyme Technologies Ltd announces Financial Results for the quarter and year ended March 2019

Kridhan Infra Ltd arm files for insolvency in Singapore

Infosys Completes Formation of Strategic Partnership with ABN AMRO in the Netherlands

Genesys International Corporation Ltd Board approves Dividend for 2018-19

I G Petrochemicals Ltd reports Q4, FY19 results

ITD Cementation India Ltd board recommends dividend of Rs. 0.40

Prima Plastics Ltd board approves dividend of Rs. 1 for FY19

Acrysil Ltd Board approves Dividend of Rs. 1.20

Munjal Auto Industries Ltd Board approves Dividend of Rs. 1

Ramco Systems FY19 revenue grows 16% and Net Profit by 45% in INR

IG Petrochemicals Ltd Board approves Dividend for FY19

Balaji Telefilms Ltd Board recommends Final Dividend for 2018-19

Sagar Cements Ltd Board recommends Dividend of Rs. 2.50

Asian Star Company Ltd board recommends dividend of Rs. 1.5







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019